Date: 6/8/2003: "As previously reported, Norwood Immunology plans to conduct its trial programme having secured a major pharmaceutical partner to cooperate in the trials and for ultimate commercialisation of the technology. Discussions with Norwood's preferred US partner are at an advanced stage".
Obviously, negotiations take time. For a start, the Partner may want to know that the Patent (s) will stand up. So they will test it (them).
I don't consider waiting to be a problem because there has been nothing but good news coming through lately.
It would be a great commercial error if such an agreement were to be signed too early as NAL is in a much stronger negotiating position now than say 6 months ago.
And that is vital to the shareholder.
Gerry
NAL Price at posting:
0.0¢ Sentiment: None Disclosure: Held
